News

Filter

1 to 9 of 97211 results

Lilly rekindles deal with Adocia to develop ultra rapid insulin

19-12-2014

US pharma major Eli Lilly and French biotech firm Adocia have entered into a worldwide licensing collaboration…

AdociaBioChaperone LisproBiotechnologyDiabetesEli LillyGlobalLicensing

Pfizer touts strong Ph III results for Lyrica CR for postherpetic neuralgia

19-12-2014

US pharma giant Pfizer has released top-line results from a double-blind Phase III study evaluating pregabalin…

LyricaNeurologicalPfizerPharmaceuticalPregabalinResearch

Gilead and Ono enter into a licensing agreement for ONO-4059

Gilead and Ono enter into a licensing agreement for ONO-4059

19-12-2014

Japanese pharma company Ono Pharmaceutical and US biotech major Gilead Sciences have entered into a licensing…

BiotechnologyGilead SciencesLicensingOncologyOno PharmaceuticalONO-4059Research

PhRMA releases new report on challenges to developing new hepatitis C treatments

PhRMA releases new report on challenges to developing new hepatitis C treatments

19-12-2014

The Pharmaceutical Research and Manufacturers of America released a new report examining the scientific…

Manufacturers of AmericaPharmaceuticalPhRMAResearchRespiratory and Pulmonary

The Medicines Company and SciClone partner for cardiovasculars in China

The Medicines Company and SciClone partner for cardiovasculars in China

19-12-2014

US drugmaker The Medicines Company and SciClone Pharmaceuticals, a USA-based, China focused specialty…

AngiomaxCardio-vascularChinaCleviprexLicensingPharmaceuticalSciClone PharmaceuticalsThe Medicines Company

Sorrento and Conkwest join forces on cancer immunotherapies development

Sorrento and Conkwest join forces on cancer immunotherapies development

19-12-2014

US cancer drug developer Sorrento Therapeutic and privately-held Conkwest have entered into a definitive…

BiotechnologyConkwestFinancialNeukoplastOncologyResearchSorrento Therapeutics

Polaris Group receives orphan drug designation for ADI-PEG 20 from the FDA

Polaris Group receives orphan drug designation for ADI-PEG 20 from the FDA

19-12-2014

Privately-held Polaris Group has received orphan drug designation for ADI-PEG 20 (pegylated arginine…

ADI-PEG 20OncologyPharmaceuticalPolaris GroupRegulation

1 to 9 of 97211 results

Back to top